Margarita-Ioanna Koufaki (Margianna Koufaki)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Cross Sectional

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Pharmacogenomics

Lung Cancer (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, Konstantinos Koufou, George P Patrinos, Christina Mitropoulou
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications. Pharmacogenomics 25 (2) (2024)
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, Konstantinos Koufou, George P Patrinos, Christina Mitropoulou
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications. Pharmacogenomics (2024)
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, Konstantinos Koufou, George P Patrinos, Christina Mitropoulou
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications. Pharmacogenomics 25 (2) (2024)
Michael Bariotakis, Luciana Georgescu, Danae Laina, Margarita-Ioanna Koufaki, Maria Souma, Sotirios Douklias, Konstantinos A Giannakakis, Kyriaki N Chouli, Luca Paoli, Stefano Loppi, Reggina Karousou, Petr Smýkal, Elias Castanas, Stergios A Pirintsos
Climate Change Dependence in Ex Situ Conservation of Wild Medicinal Plants in Crete, Greece. Biology 12 (10) (2023)
Giannis S Mountzios, Sofia Lampaki, Georgia-Angeliki Koliou, Athanassios Vozikis, Ioannis Kontogiorgos, Panagiotis Papantoniou, Margarita-Ioanna Koufaki, Eleni Res, Anastasios Boutis, Athina Christopoulou, Nicoleta Pastelli, Anastasios Grivas, Gerasimos Aravantinos, Efthalia Lalla, Georgios Oikonomopoulos, Anna Koumarianou, Dionisios Spyratos, Dimitrios Bafaloukos, Georgios Rigakos, Pavlos Papakotoulas, George Fountzilas, Helena Linardou
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece. Lung Cancer (Auckland, N.Z.) 12 (2021)